2 stories mentioning LIVNUpdated 8d ago
Every FINWIRES story that references LIVN, newest first.
Francesco Bianchi, Director, on September 10, 2026, sold 3,500 shares in Livanova (LIVN) for $273,032. Following the Form 4 filing with the SEC, Bianchi has control over a total of 4,434 ordinary shares of the company, with 4,434 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1639691/000163969126000104/xslF345X05/wk-form4_1789417415.xml
LivaNova (LIVN) said new data showed its PolySync programming algorithm raised the cumulative response rate to 84.5% in moderate to severe obstructive sleep apnea patients by converting most non-responders after reprogramming.The findings build on earlier results showing a 65% responder rate after 12 months of therapy delivered by the company's aura6000 system, LivaNova said Tuesday in a statement.Reprogramming non-responders with simultaneous-contact stimulation significantly improved outcomes and produced no serious adverse events, the company said.LivaNova plans to file a premarket approval supplement application with the US Food and Drug Administration in H2 for a next-generation device with MRI compatibility and other upgrades.Price: $80.53, Change: $+0.83, Percent Change: +1.04%
